FASTING MIMICKING TECHNOLOGY

THE NUTRITION BREAKTHROUGH
OF THE CENTURY.

The discovery of Fasting Mimicking Technology was a breakthrough in the Food as Medicine Movement. Discovered and developed at the Longevity Institute of the University of Southern California, our technology is plant-based nutrition that allows the body to enter into a beneficial fasting state without triggering the cells’ nutrient sensors. As the name suggests, it actually mimics fasting…while still allowing you to eat food. This nourished fasting fine-tunes cells, supports healthy aging, and eliminates the need to do a water-only starvation fast, which can have negative side effects.

Fasting Mimicking Technology is the basis for many products we continue to develop for specific applications with the aim of improving health, longevity and the human healthspan.

partner

HOW IT WORKS

THE LIFE CHANGING POWER OF CELLULAR & METABOLIC REJUVENATION.

At inception, Fasting Mimicking Technology development was focused on supporting a five day fast followed by a return to a normal diet. It’s a fasting approach called periodic fasting. The results, based on years of research into fasting and this specific approach, are simply astounding. Periodic fasting triggers cellular protection and rejuvenation pathways collectively known as autophagy (autophagy is so important to health and longevity that research in the subject was awarded the 2016 Nobel Prize in Medicine). Simply put, autophagy is your body’s natural, too-often-untapped system for replacing and renewing old, worn out cellular components.

Our remarkable discovery was that our Fasting Mimicking Technology could trigger and sustain autophagy during the fast, while providing essential nutrients. In other words, it activates the body’s powerful cell rejuvenating system to encourage healthy aging and reduces hunger during fasting at the same time.

partner

A GAME CHANGER IN LONGEVITY AND HEALTHSPAN.

Beyond individual health benefits, Fasting Mimicking Technology is a true breakthrough with the potential to change the course of health care. In fact, recent studies have uncovered potential therapeutic effects of this technology platform on numerous chronic health conditions such as diabetes, cancer, Alzheimer’s, and various cardiovascular and autoimmune diseases. L-Nutra, through its drug development arm, is currently developing and testing specific formulations based on the Fasting Mimicking Technology platform for patients with each of these conditions.

THE PATH TO DISCOVERY.

Fasting Mimicking Technology was developed at the Longevity Institute of the University of Southern California by a team of researchers led by Professor Valter Longo. After over a decade of research into the powerful health benefits of water fasting in mice, the researchers attempted to test water fasting in humans but quickly ran into compliance and safety issues that threatened their progress. However, the National Institutes of Health (NIH) recognized the importance of the project and granted millions of dollars to the team with the specific goal of developing Fasting Mimicking Technology (and thereby eliminating the need to test water-only fasting). The rest is history.

Today, based on promising results from our preclinical studies and early human trials, 16 top universities across the globe are testing a Fasting Mimicking Technology formulation for applications in longevity and disease prevention. Many institutions have also continued to work with L-Nutra in researching other Fasting Mimicking Technology formulations as therapies for the top five most lethal diseases known to mankind – diabetes, cancer, Alzheimer’s, and cardiovascular and autoimmune diseases.

partner

SERIOUS SCIENCE.
GLOBAL PATENTS.

Due to the overwhelming research and scientific evidence behind Fasting Mimicking Technology, it has been awarded numerous patents both in the United States and from patent offices around the globe. In addition, Fasting Mimicking Technology is the only nutrition program in the world with human research trials and fully-granted patents in the areas of longevity, cancer, Alzheimer’s, cardiovascular and auto-immune diseases.

Methods and Formulations Promoting Tissue/Organ
Regeneration, Longevity and Healthspan.

Patent Number: US10015980
Publication Date: July 10, 2018
Inventors: Valter D. Longo, Sebastian Brankhorst, Levine, Chia-Wei Cheng, Min Wei

partner